Pattern of Antipsychotics in Schizophrenia Outpatients at Lampung Province Mental Hospital
Schizophrenia as a chronic mental disorder, has increased in number in the last three decades DALYs (Disability Adjusted Life Years). Antipsychotics have been the mainstay of treatment. The use of combinations of typical/atipycal antipsychotic active substances is very often done. The purpose of th...
| 出版年: | Jurnal Ilmiah Medicamento |
|---|---|
| 第一著者: | Isnenia Isnenia |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
Universitas Mahasaraswati Denpasar
2022-03-01
|
| 主題: | |
| オンライン・アクセス: | https://e-journal.unmas.ac.id/index.php/Medicamento/article/view/3201 |
類似資料
Antipsychotic polypharmacy in a regional health service: a population-based study
著者:: Bernardo Miguel, 等
出版事項: (2012-05-01)
著者:: Bernardo Miguel, 等
出版事項: (2012-05-01)
Constipation‐associated factors in outpatients with schizophrenia: A multicenter questionnaire survey
著者:: Taro Tazaki, 等
出版事項: (2024-09-01)
著者:: Taro Tazaki, 等
出版事項: (2024-09-01)
Pharmacoeconomic assessment of antipsychotic treatment in outpatients with schizophrenia
著者:: I. A. Vilyum, 等
出版事項: (2018-05-01)
著者:: I. A. Vilyum, 等
出版事項: (2018-05-01)
Prescription of Anticholinergic Drugs in Patients With Schizophrenia: Analysis of Antipsychotic Prescription Patterns and Hospital Characteristics
著者:: Hikaru Hori, 等
出版事項: (2022-05-01)
著者:: Hikaru Hori, 等
出版事項: (2022-05-01)
Combination treatment with second generation antipsychotics other than clozapine
著者:: C. Schmidt-Kraepelin
出版事項: (2021-04-01)
著者:: C. Schmidt-Kraepelin
出版事項: (2021-04-01)
Polypharmacy Management of Antipsychotics in Patients with Schizophrenia
著者:: Hiroyuki Kamei
出版事項: (2022-11-01)
著者:: Hiroyuki Kamei
出版事項: (2022-11-01)
Study of factors associated with obesity in patients using antipsychotics in schizophrenia
著者:: Vishalakshi Patnam, 等
出版事項: (2024-12-01)
著者:: Vishalakshi Patnam, 等
出版事項: (2024-12-01)
The Effect of Antipsychotics on Cognition in Schizophrenia—A Current Narrative Review
著者:: Petru Fabian Lungu, 等
出版事項: (2024-04-01)
著者:: Petru Fabian Lungu, 等
出版事項: (2024-04-01)
Prescription pattern of antipsychotics in patients with schizophrenia: An observational study at a tertiary care hospital in rural Karnataka
著者:: Nameerah Javed, 等
出版事項: (2024-12-01)
著者:: Nameerah Javed, 等
出版事項: (2024-12-01)
Atypical antipsychotics in the treatment of schizophrenia
著者:: Swiss Medical Weekly
出版事項: (2003-02-01)
著者:: Swiss Medical Weekly
出版事項: (2003-02-01)
Patterns and predictors of oral antipsychotic prescribing in adult patients with schizophrenia
著者:: Nina Vadiei, 等
出版事項: (2022-06-01)
著者:: Nina Vadiei, 等
出版事項: (2022-06-01)
Effectiveness of antipsychotics in schizophrenia with comorbid substance use disorder
著者:: M. Lähteenvuo, 等
出版事項: (2021-04-01)
著者:: M. Lähteenvuo, 等
出版事項: (2021-04-01)
The antipsychotics functional index (AFI) in schizophrenia
著者:: Gabriel-Cristian Marinescu, 等
出版事項: (2025-07-01)
著者:: Gabriel-Cristian Marinescu, 等
出版事項: (2025-07-01)
The treatment characteristics of oral antipsychotics in treatment of adolescents with schizophrenia in China
著者:: Huaning Wang, 等
出版事項: (2025-07-01)
著者:: Huaning Wang, 等
出版事項: (2025-07-01)
Correction: The antipsychotics functional index (AFI) in schizophrenia
著者:: Gabriel-Cristian Marinescu, 等
出版事項: (2025-07-01)
著者:: Gabriel-Cristian Marinescu, 等
出版事項: (2025-07-01)
Sexual differences in the clinical features of antipsychotic-induced hyperprolactinemia in patients with schizophrenia
著者:: E. G. Kornetova, 等
出版事項: (2019-10-01)
著者:: E. G. Kornetova, 等
出版事項: (2019-10-01)
Analysis of Oral versus Long-acting Injectable Antipsychotics in the Maintenance of Schizophrenia
著者:: O. Vasiliu
出版事項: (2022-06-01)
著者:: O. Vasiliu
出版事項: (2022-06-01)
Evaluation of naltrexone augmentation to the antipsychotic drugs on positive and negative symptoms of schizophrenia
著者:: Javad Setareh, 等
出版事項: (2008-01-01)
著者:: Javad Setareh, 等
出版事項: (2008-01-01)
Schizophrenia long-acting antipsychotics initiation index (SLAAII)
著者:: P. Ifteni, 等
出版事項: (2021-04-01)
著者:: P. Ifteni, 等
出版事項: (2021-04-01)
Antipsychotics-related hyperprolactinaemia among patients with schizophrenia in Maiduguri
著者:: Falmata B. Shettima, 等
出版事項: (2024-02-01)
著者:: Falmata B. Shettima, 等
出版事項: (2024-02-01)
Early Markers in Resistant Schizophrenia: Effect of the First Antipsychotic Drug
著者:: Georgi Panov Panov
出版事項: (2022-03-01)
著者:: Georgi Panov Panov
出版事項: (2022-03-01)
Impact of second-generation antipsychotics monotherapy or combined therapy in cytokine, lymphocyte subtype, and thyroid antibodies for schizophrenia: a retrospective study
著者:: Xiaonan Guo, 等
出版事項: (2024-10-01)
著者:: Xiaonan Guo, 等
出版事項: (2024-10-01)
Effects of Psychostimulants and Antipsychotics on Serum Lipids in an Animal Model for Schizophrenia
著者:: Banny Silva Barbosa Correia, 等
出版事項: (2021-02-01)
著者:: Banny Silva Barbosa Correia, 等
出版事項: (2021-02-01)
Effects of antipsychotic and anticholinergic medications on cognition in chronic patients with schizophrenia
著者:: Chadia Haddad, 等
出版事項: (2023-01-01)
著者:: Chadia Haddad, 等
出版事項: (2023-01-01)
Weight Gain, Mental Symptoms and Self-Esteem in Patients with Schizophrenia
著者:: Sevde Öner, 等
出版事項: (2022-12-01)
著者:: Sevde Öner, 等
出版事項: (2022-12-01)
Pharmacoeconomic analysis of using typical and atypical antipsychotics in schizophrenia
著者:: I. A. Vilyum, 等
出版事項: (2018-08-01)
著者:: I. A. Vilyum, 等
出版事項: (2018-08-01)
Study of adverse effects of extrapyramidal syndrome use of combination of antipsychotics antidepressants in outpatient schizophrenia patients in RSUP Fatmawati for the period 2016-2020
著者:: Ema Nillafita Putri Kusuma, 等
出版事項: (2023-07-01)
著者:: Ema Nillafita Putri Kusuma, 等
出版事項: (2023-07-01)
Pharmacogenetics and Schizophrenia—Can Genomics Improve the Treatment with Second-Generation Antipsychotics?
著者:: Olga Płaza, 等
出版事項: (2022-12-01)
著者:: Olga Płaza, 等
出版事項: (2022-12-01)
Metabolic disturbances in patients with paranoid schizophrenia treated with atypical antipsychotic drugs
著者:: Leonid Mikhaylovich Bardenshteyn, 等
出版事項: (2010-06-01)
著者:: Leonid Mikhaylovich Bardenshteyn, 等
出版事項: (2010-06-01)
Practical Guidance for the Use of Long-Acting Injectable Antipsychotics in the Treatment of Schizophrenia
著者:: Riboldi I, 等
出版事項: (2022-12-01)
著者:: Riboldi I, 等
出版事項: (2022-12-01)
Effectiveness of antipsychotic medication in patients with schizophrenia in a real world retrospective observational study in Ethiopia
著者:: Mulualem Kelebie, 等
出版事項: (2025-02-01)
著者:: Mulualem Kelebie, 等
出版事項: (2025-02-01)
Investigating the Effect of Adherence to Antipsychotic Therapy on the Length of Stay and Number of Hospitalizations in Patients with Schizophrenia – A Descriptive Analysis
著者:: Barliana MI, 等
出版事項: (2023-11-01)
著者:: Barliana MI, 等
出版事項: (2023-11-01)
The Novel Antipsychotic Lumateperone (Iti-007) in the Treatment of Schizophrenia: A Systematic Review
著者:: Giulio Longo, 等
出版事項: (2023-11-01)
著者:: Giulio Longo, 等
出版事項: (2023-11-01)
Acute overdose of antipsychotics and antidepressants by patient with paranoid schizophrenia - a case report
著者:: Anna Katarzyna Orzeł, 等
出版事項: (2019-09-01)
著者:: Anna Katarzyna Orzeł, 等
出版事項: (2019-09-01)
Adverse effects of antipsychotics on sleep in patients with schizophrenia. Systematic review and meta-analysis
著者:: Yarmila Elena Valencia Carlo, 等
出版事項: (2023-06-01)
著者:: Yarmila Elena Valencia Carlo, 等
出版事項: (2023-06-01)
Comparison of antipsychotic prescribing practices following failure of antipsychotic monotherapy in the acute care setting
著者:: Kaitlyn Morgan, PharmD, BCPP, 等
出版事項: (2023-01-01)
著者:: Kaitlyn Morgan, PharmD, BCPP, 等
出版事項: (2023-01-01)
Recent trends in antipsychotic polypharmacy in the treatment of schizophrenia
著者:: Norio Yasui‐Furukori, 等
出版事項: (2020-09-01)
著者:: Norio Yasui‐Furukori, 等
出版事項: (2020-09-01)
The Prevalence of Tardive Dyskinesia In Patients With Schizophrenia Treated With Antipsychotics In Malaysia
著者:: Nedunjelian A, 等
出版事項: (2025-03-01)
著者:: Nedunjelian A, 等
出版事項: (2025-03-01)
CLINICAL AND SOCIAL RISK FACTORS OF TARDIVE DYSKINESIA IN PATIENTS WITH SCHIZOPHRENIA DURING ANTIPSYCHOTIC TREATMENT
著者:: Ye. G. Kornetova, 等
出版事項: (2015-02-01)
著者:: Ye. G. Kornetova, 等
出版事項: (2015-02-01)
Factors associated with high‐dose antipsychotic prescriptions in outpatients with schizophrenia: An analysis of claims data from a Japanese prefecture
著者:: Tatsuichiro Takahashi, 等
出版事項: (2020-09-01)
著者:: Tatsuichiro Takahashi, 等
出版事項: (2020-09-01)
類似資料
-
Antipsychotic polypharmacy in a regional health service: a population-based study
著者:: Bernardo Miguel, 等
出版事項: (2012-05-01) -
Constipation‐associated factors in outpatients with schizophrenia: A multicenter questionnaire survey
著者:: Taro Tazaki, 等
出版事項: (2024-09-01) -
Pharmacoeconomic assessment of antipsychotic treatment in outpatients with schizophrenia
著者:: I. A. Vilyum, 等
出版事項: (2018-05-01) -
Prescription of Anticholinergic Drugs in Patients With Schizophrenia: Analysis of Antipsychotic Prescription Patterns and Hospital Characteristics
著者:: Hikaru Hori, 等
出版事項: (2022-05-01) -
Combination treatment with second generation antipsychotics other than clozapine
著者:: C. Schmidt-Kraepelin
出版事項: (2021-04-01)
